Literature DB >> 3495630

The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host-diseased mice.

A G Rolink, T Radaszkiewicz, F Melchers.   

Abstract

A quantitative analysis of the frequencies of autoantibody-producing B cells in GVHD and in normal mice has been undertaken by generating collections of hybridomas of activated B cells. These hybridomas secreted sufficient quantities of Ig to allow binding analyses on a panel of autoantigens. B cells have been activated in a variety of ways. In vivo they were activated by injection of alloreactive T cells of one parent, leading to GVHD by a foreign antigen, sheep erythrocytes, in a secondary response, or by the polyclonal activator LPS. B cells from an experimentally unstimulated animal were used for an analysis of the normal background. In vitro B cells were activated by alloreactive T cells or by LPS. The frequencies of hybridomas and, therefore, of activated B cells producing autoantibodies to DNA or to kidney were not significantly different in mice activated by a graft-vs.-host T cell response as compared with B cell populations activated by any of the other procedures. They were found to compose 7.1-17.1% of the total repertoire of activated B cells. Moreover, the frequencies of autoantibody-producing activated B cells does not change with time after induction of the graft-vs.-host reaction. The pattern and frequencies of autoantigen-binding specificities to cytoskeleton, smooth muscle, nuclei, mitochondria, and DNA were not found to be different in any of the groups of hybridomas. The single notable exception, found in GVHD mice, were hybridomas producing autoantibodies to kidney proximal tubular brush border. These results allow the conclusion that autoantigen-binding B cells exist in an activated state in GVHD mice, as well as in mice activated by a foreign antigen or by a polyclonal activator, in B cell populations activated in vitro either by alloreactive T cells or by a polyclonal activator, and even in the background of experimentally unstimulated animals. T cell-mediated graft-vs.-host activation, in large part, does not lead to a selective expansion of autoantigen-binding B cells. The main difference between the graft-vs.-host-activated B cell repertoire and all others is that approximately 90% of teh autoantibodies were of the IgG class, whereas al autoantibodies found in the other groups were IgM.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495630      PMCID: PMC2188368          DOI: 10.1084/jem.165.6.1675

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  The antibody repertoire of hybrid cell lines obtained by fusion of X63-AG8 myeloma cells with mitogen-activated B-cell blasts.

Authors:  J Andersson; F Melchers
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

4.  Cloning of murine transformed cell lines in suspension culture with efficiencies near 100%.

Authors:  W Lernhardt; J Andersson; A Coutinho; F Melchers
Journal:  Exp Cell Res       Date:  1978-02       Impact factor: 3.905

5.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

6.  Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization.

Authors:  B Guilbert; G Dighiero; S Avrameas
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

7.  Allogeneic interactions in the immune response and tolerance. I. The allogeneic effect in unprimed rats and mice.

Authors:  E P Ornellas; D W Scott
Journal:  Cell Immunol       Date:  1974-03-30       Impact factor: 4.868

8.  A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE.

Authors:  E Gleichmann; E H Van Elven; J P Van der Veen
Journal:  Eur J Immunol       Date:  1982-02       Impact factor: 5.532

9.  Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes.

Authors:  N N Iscove; F Melchers
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

10.  Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T-B cell cooperation across I-E.

Authors:  F M van Rappard-van der Veen; A G Rolink; E Gleichmann
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  19 in total

1.  Accelerated expression of anti-Sm and Y2 idiotype differ in dependence on T cell subsets in MRL/+ mice.

Authors:  M L Miller; H Dang; N Talal
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

2.  Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease.

Authors:  L Rozendaal; S T Pals; E Gleichmann; C J Melief
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Therapeutic effect of leflunomide on the development of experimental lupus nephritis in mice.

Authors:  Chunyan He; Xuehong Lu; Zhaowei Yan; Man Wu; Shujun Liu; Yongli Yu; Ping Luo
Journal:  Rheumatol Int       Date:  2010-12-03       Impact factor: 2.631

4.  Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.

Authors:  P Appleby; D G Webber; J G Bowen
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

Review 5.  Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease.

Authors:  R Smeenk; K Brinkman; H van den Brink; R M Termaat; J Berden; H Nossent; T Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

6.  Murine monoclonal antibodies to DNA. A comparison of MRL/lpr NZB/W and chronically graft-versus-host-diseased mice.

Authors:  K Brinkman; A van Dam; H van den Brink; R M Termaat; J Berden; R Smeenk
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

7.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.

Authors:  A Strasser; S Whittingham; D L Vaux; M L Bath; J M Adams; S Cory; A W Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease.

Authors:  J A Bruijn; P C Hogendoorn; W E Corver; L J van den Broek; P J Hoedemaeker; G J Fleuren
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

9.  Liver-expressed Igkappa superantigen induces tolerance of polyclonal B cells by clonal deletion not kappa to lambda receptor editing.

Authors:  Takayuki Ota; Miyo Ota; Bao Hoa Duong; Amanda L Gavin; David Nemazee
Journal:  J Exp Med       Date:  2011-02-28       Impact factor: 14.307

10.  Ly1+ PRO-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo.

Authors:  R Palacios; H Karasuyama; A Rolink
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.